PrimeX News

Broker News

Illumina (ILMN): Bullish Structure Builds After Breakout
Tue, 09 Jun 2026 21:10:51 GMT
Crude Oil Price Forecast: Triangle Breakdown Signals Downside Risk
Tue, 09 Jun 2026 21:03:45 GMT
Gold (XAU/USD) Price Forecast: Bearish Pressure Builds After Breakdown
Tue, 09 Jun 2026 20:58:24 GMT
Natural Gas Price Forecast: Resistance Holds as Breakdown Risk Grows
Tue, 09 Jun 2026 20:52:57 GMT
NASDAQ Index, SP500, Dow Jones Forecasts – NASDAQ Retreats As Traders Sell Tech Stocks
Tue, 09 Jun 2026 19:28:23 GMT
Natural Gas, WTI Oil, Brent Oil Forecasts – Oil Retreats As Traders Ignore Iran’s Attack On A U.S. Helicopter
Tue, 09 Jun 2026 18:45:25 GMT

ECB, Bank of England Set to Hold Rates Unchanged Today
Thu, 30 Apr 2026 13:08:34 GMT
Nasdaq 100: Meta Falls as Amazon Slips, Microsoft, Alphabet Diverge
Wed, 29 Apr 2026 21:43:04 GMT
Hungary’s Euro Ambition Is a Long-term Bet Requiring Discipline, Credibility and Integration
Mon, 13 Apr 2026 16:16:44 GMT
A Divided Fed to Continue Favouring Easing Even as the Iran War Raises the Stakes
Thu, 26 Mar 2026 21:25:31 GMT
ECB Policy to Ultimately Be Determined by the Fallout from the Iran War
Mon, 16 Mar 2026 13:30:15 GMT
Jobs Miss and Oil Spike Signal Stagflation Risk for U.S. Economy
Fri, 20 Mar 2026 20:24:14 GMT

RSI Indicator Explained: How to Read Momentum and Time Trades in 2026
Wed, 03 Jun 2026 21:56:39 GMT
Fibonacci Retracements Explained: How to Spot Key Reversal Levels in 2026
Thu, 28 May 2026 12:22:53 GMT
How Renko Charts Filter Market Noise & Improve Trend Analysis
Sun, 10 May 2026 14:02:44 GMT
Getting an Edge From Factor Investing
Sat, 09 May 2026 10:43:54 GMT
US Sector Rotation Strategy: Using the Business Cycle & RRG Charts to Find Market Leaders
Sun, 03 May 2026 16:49:46 GMT
What Are Leveraged and Inverse ETFs? Risks, Rewards, and Key Strategies
Mon, 23 Mar 2026 23:55:30 GMT

Advertisement

Advertisement

ATOS

Atossa Therapeutics, Inc. Common Stock

4.41

USD

-0.14

-3.08%

Jun 09, 16:00 UTC -4

Closed

exchange

After-Market

4.25

-0.16

-3.72%

ATOS News & Forecasts

featured

Atossa Therapeutics, Inc. (ATOS) Discusses Challenges in Breast Cancer Drug Development and Innovation in Clinical Research Transcript

Advertisement

Advertisement

Advertisement